The Latest Breaking News from FDA

How common is Paxlovid rebound as Jill Biden tests positive again for Covid?

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

The Independent UK · Aug 25, 2022

Congressman’s wife died after taking herbal remedy marketed for diabetes and weight loss

SACRAMENTO, Calif. — The wife of a Northern California congressman died late last year after ingesting a plant that is generally considered safe and is used as an herbal remedy for a variety of ailments, including diabetes, obesity and high cholesterol, KHN has learned.

Tribune News Service · Aug 25, 2022

Recap Of Wednesday's Biotech Catalysts - End Of the Day Summary

The European Commission (EC) has granted conditional marketing authorization (CMA) to BioMarin Pharmaceutical’s (NASDAQ:BMRN) lead asset ROCTAVIAN (valoctocogene roxaparvovec) gene therapy for the treatment of severe hemophilia A (congenital Factor VIII deficiency) in adult patients. BioMarin shares traded as high as 2.28 percent, in a range of $91.39 to $93.68…

Benzinga · Aug 24, 2022

Taking Care Of Cannabis Consumers, Federal Trade Commission Issues Refunds To CBD Buyers, Here's Why

Recently, the Federal Trade Commission (FTC) announced that it will send payments to 576 consumers across the country who purchased 'deceptively marketed' cannabidiol (CBD) products from Arizona-based Kushly Industries LLC.

Benzinga · Aug 24, 2022

Senate Candidate Dr. Oz, Who Once Sang Pot's Praises, Now Thinks Supporting Legalization Is Clearly Crazy

The former TV doctor, who two years ago said "we ought to completely change our policy on marijuana," mocks his opponent for agreeing.

Reason · Aug 24, 2022

How common is Paxlovid rebound as Jill Biden tests positive again for Covid?

Paxlovid good at stopping hospitalisation for high-risk groups, despite occasional rebound

The Independent UK · Aug 24, 2022

Panel details pressure campaign for unproven COVID treatment

A special House panel looking into the government's coronavirus response says the Trump White House tried to pressure U.S. health experts into reauthorizing the anti-malaria drug hydroxychloroquine that had been discredited as a COVID-19 treatment

The Independent UK · Aug 24, 2022

A Cop Rear-Ended a Car, Sending a Toddler to the Hospital. The Car's Driver Was Breathalyzed. The Cop Wasn't.

Plus: Twitter whistleblower reports, court says FDA must reconsider vaping products, and more...

Reason · Aug 24, 2022

More communities are giving flavored tobacco the boot. Will California follow?

SAN JOSE, Calif. — California’s third-largest city banished flavored tobacco products from store shelves this summer, joining scores of other cities and counties in the state in a public health push to reduce nicotine addiction among youths and young adults.

Tribune News Service · Aug 24, 2022

Advocates urge FDA action to ease policing fears in menthol ban

WASHINGTON — Experts and advocates are calling on the Biden administration to do more to avoid potential confrontations between police and racial minorities if the Food and Drug Administration finalizes a ban on menthol cigarettes.

Tribune News Service · Aug 24, 2022